Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

New England Journal of Medicine ◽

10.1056/nejm199311183292102 ◽

1993 ◽

Vol 329 (21) ◽

pp. 1524-1530 ◽

Author(s):

Jessie R. Groothuis ◽

Eric Simoes ◽

Myron J. Levin ◽

Caroline B. Hall ◽

Christine E. Long ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Young Children ◽

Immune Globulin ◽

Prophylactic Administration ◽

Syncytial Virus ◽

High Risk Infants ◽

Infants And Young Children

Download Full-text

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children

The Journal of Pediatrics ◽

10.1016/s0022-3476(05)81383-6 ◽

1994 ◽

Vol 124 (5) ◽

pp. 821-822

Author(s):

Groothuis JR ◽

Simoes EAF ◽

Levin MJ

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Young Children ◽

Immune Globulin ◽

Prophylactic Administration ◽

Syncytial Virus ◽

High Risk Infants ◽

Infants And Young Children

Download Full-text

Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children

The Journal of Immunology ◽

10.4049/jimmunol.179.5.3171 ◽

2007 ◽

Vol 179 (5) ◽

pp. 3171-3177 ◽

Author(s):

Agnes A. Awomoyi ◽

Prasad Rallabhandi ◽

Toni I. Pollin ◽

Eva Lorenz ◽

Marcelo B. Sztein ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Young Children ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants ◽

Infants And Young Children

Download Full-text

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

Antimicrobial Agents and Chemotherapy ◽

10.1128/aac.37.8.1655 ◽

1993 ◽

Vol 37 (8) ◽

pp. 1655-1658 ◽

Author(s):

H C Meissner ◽

D R Fulton ◽

J R Groothuis ◽

R L Geggel ◽

G R Marx ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Immune Globulin ◽

Virus Disease ◽

Controlled Trial ◽

Intravenous Immune Globulin ◽

Respiratory Syncytial Virus Disease ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Palivizumab and respiratory syncytial virus immune globulin intravenous for the prophylaxis of respiratory syncytial virus infection in high risk infants

Paediatrics & Child Health ◽

10.1093/pch/4.7.474 ◽

1999 ◽

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Immune Globulin ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Respiratory Syncytial Virus-Associated Mortality in Hospitalized Infants and Young Children

10.1542/peds.2014-2151d ◽

2014 ◽

Vol 135 (1) ◽

pp. X16-X16

Keyword(s):

Respiratory Syncytial Virus ◽

Young Children ◽

Syncytial Virus ◽

Infants And Young Children

Download Full-text

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd009417.pub2 ◽

2019 ◽

Author(s):

Sharon L Sanders ◽

Sushil Agwan ◽

Mohamed Hassan ◽

Mieke L van Driel ◽

Chris B Del Mar

Keyword(s):

Respiratory Syncytial Virus ◽

Virus Infection ◽

Young Children ◽

Respiratory Syncytial Virus Infection ◽

Immunoglobulin Treatment ◽

Syncytial Virus ◽

Infants And Young Children

Download Full-text

Palivizumab for immunoprophylaxis of respiratory syncitial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses

Health Technology Assessment ◽

10.3310/hta15050 ◽

2011 ◽

Vol 15 (05) ◽

Author(s):

D Wang ◽

S Bayliss ◽

C Meads

Keyword(s):

Systematic Review ◽

High Risk ◽

Young Children ◽

Economic Modelling ◽

Subgroup Analyses ◽

High Risk Infants ◽

Infants And Young Children

Download Full-text

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-ESCALATION TRIAL OF A HUMANIZED RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL ANTIBODY (MEDI-493) IN HIGH RISK INFANTS. • 768

Pediatric Research ◽

10.1203/00006450-199704001-00788 ◽

1997 ◽

Vol 41 ◽

pp. 130-130

Author(s):

K. N. Siva Subramanian ◽

L. Weisman ◽

T. Rhodes ◽

E. Connor

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Dose Escalation ◽

Double Blind ◽

Double Blind Placebo ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

10.1542/9781610020862-part05-updated_guidance_for ◽

2017 ◽

pp. 1504-1504

Keyword(s):

Respiratory Syncytial Virus ◽

Virus Infection ◽

Young Children ◽

Respiratory Syncytial Virus Infection ◽

Increased Risk ◽

Syncytial Virus ◽

Infants And Young Children

Download Full-text

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

10.1542/9781610020190-part05-updated ◽

2016 ◽

pp. 1362-1362

Keyword(s):

Respiratory Syncytial Virus ◽

Virus Infection ◽

Young Children ◽

Respiratory Syncytial Virus Infection ◽

Increased Risk ◽

Syncytial Virus ◽

Infants And Young Children

Download Full-text